circuit-chip-processor.jpgIPNews® – Tela Innovations Inc. has filed lawsuits with the Delaware federal court and the International Trade Commission alleging that five technology giants, including Nokia Corp. and LG Electronics Inc., have infringed seven of its patents by importing and selling smartphones containing integrated circuits manufactured using its patented technology.

California-based Tela claims that Motorola Mobility LLC, HTC Corp., and Pantech Co. Ltd., in addition to Nokia and LG, have copied Tela’s manufacturing method for optimizing the layout of an integrated circuit.  Tela is asking the court for damages and for an injunction barring the companies from importing infringing goods. 

To continue reading, click: Nokia, LG Accused of Infringing Integrated Circuit Patents

ukulele.jpgIPNews® – Viacom International Inc. urged a Los Angeles judge to dismiss a lawsuit brought by Gibson Guitar Corp. for infringing a trademarked “Flying V” electric guitar, claiming that the allegedly infringing ukuleles were never sold in the United States.

Viacom, owner of the Nickelodeon television network, filed a motion to dismiss claiming the v-shaped ukuleles were manufactured in China and distributed only in Asia, Europe and South America thus there is no subject matter jurisdiction in the United States.  The ukuleles feature Viacom’s character SpongeBob SquarePants.

To continue reading, click: Viacom Asks Judge to Dismiss Gibson’s Trademark Infringement Lawsuit

supplements.jpgIPNews® – Neptune Technologies & Bioressources Inc. has lodged a complaint against several krill oil supplement manufacturers, claiming their products infringe its patent.

In its complaint to the U.S. International Trade Commission, Neptune claimed that a group of companies are selling products that infringe on its patented method of extracting oil from krill.  The company is requesting an order preventing the alleged infringers from importing, marketing or selling their krill oil products in the United States.

To continue reading, click: Krill Oil Manufacturer Sues Competitors for Patent Infringement

hershey_kisses.jpgIPNews® – Shaw Industries Group Inc., the world’s leading manufacturer of carpet and flooring, filed a lawsuit against Hershey Co. seeking a declaratory judgment that Shaw’s “Chocolate Kiss” carpet color does not infringe Hershey’s KISS related trademarks.

In the complaint, Shaw claims it has been selling “Chocolate Kiss” colored flooring for over 20 years without any known confusion with Hershey’s miniature chocolates.  Shaw claims that Hershey is threatening it with legal action and it is seeking declaratory relief to protect it from further losses until it can complete its planned phase out of the color by June of this year.

To continue reading, click: Does “Chocolate Kiss” Colored Flooring Infringe on Hershey’s Trademarks?

facebook.jpgIPNews® – Rembrandt Social Media LP sued Facebook Inc. in Virginia claiming Facebook is infringing two of its patents with its “Like” button and other sharing technology.

Rembrandt claims that it owns two patents covering technology that allows users to create a personal webpage and pull content from third party sources without any training in computer programming.  Rembrandt claims that in addition to sharing technology, Facebook copied nearly everything about its website from its patents, including the idea of placing advertisements on personal web diaries to turn a profit.

To continue reading, click: Facebook Accused of Infringing Patents with “Like” Button 

pills.jpgIPNews® – Purdue Pharma LP filed a lawsuit in New York on Friday claiming that two generic drug manufacturers’ planned generic versions of the “abuse-proof” form of OxyContin will infringe two patents licensed to the company.

Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug.  Purdue asked the court for an injunction preventing the companies from making the generic versions of the painkiller, claiming the release of a generic form of the drug would cause irreparable harm to Purdue.

To continue reading, click: OxyContin Manufacturer Sues Generics Makers for Patent Infringement

batman-keys.jpgIPNews® – A custom car designer asked the California Central District to throw out DC Comics Inc’s lawsuit alleging he infringed on its trademarks and copyrights by selling replica Batmobiles.

Gotham Garage owner Mark Towle argued that DC Comics knew he had been building Batmobiles since 2003 and yet never told him to stop or informed him that he was infringing on its trademarks and copyrights.  He also argued that the lawsuit should not be allowed to proceed as the company did not suffer any damages from his sales of the Batmobile.

To continue reading, click: DC Comics Sues Batmobile Maker for Trademark and Copyright Infringement

ipad-iphone.jpgIPNews® – A district judge denied both Apple and Samsung’s post-trial motions on Tuesday that challenged the $1.05 billion patent infringement judgment against Samsung.

Apple and Samsung were both denied motions for a new trial and Apple lost it bid for treble damages as the company did not adequately prove that Samsung had willfully infringed its patents.  Samsung lost its bid to lower the amount of damages based on its arguments that the jury had improperly calculated the damages and that Apple’s patents were invalid.

To continue reading, click: District Judge Denies Apple, Samsung’s Post-Trial Motions

pills-tablets.jpgIPNews® – The Federal Circuit ruled in favor of pharmaceutical giant Allergan, saying that two generic-drug manufacturers would infringe its patent if they attempted to make a generic form of Lumigan, a patented drug for glaucoma patients.

Barr Laboratories, Inc. and Sandoz, Inc. were found by the lower court to not have sufficiently proven their claims that Allergan’s patent was invalid due to prior art and obviousness.  The Federal Circuit upheld the decision and banned the companies from making a generic form of the drug until the patent expires.

To continue reading, click:  Allergan Wins Patent Infringement Suit Against Generic-Drug Manufacturers

pills.jpgIPNews® – Pfizer Inc. and Northwestern University filed a lawsuit on Friday in an attempt to prevent a generic-drug manufacturer from producing a form of the patented drug Lyrica.

The company and the university have actively fought to protect the patent for the drug, which brought in more than $3.7 billion in revenues in 2011.  Wockhardt Ltd. claims that the patent should be invalid due to obviousness and is attempting to obtain permission to manufacture and distribute a generic form of the drug in America.

To continue reading, click:  Pfizer Claims Generic-Drug Makers Infringe Lyrica Patent